resurg
pertussi
diseas
document
unit
state
nearli
bordetella
pertussi
case
report
washington
state
highest
year
respiratori
season
clinic
differenti
pertussi
viral
pathogen
problemat
pediatr
popul
especi
young
children
identif
pertussi
well
agent
caus
respiratori
cough
import
implic
patient
care
vaccin
recommend
antimicrobi
stewardship
implement
appropri
communitybas
infect
prevent
histor
laboratori
diagnosi
pertussi
respiratori
viral
pathogen
requir
technic
demand
method
maintain
special
laboratori
polymerasechainreact
pcr
greatli
improv
test
sensit
reduc
timetoresult
enabl
pathogen
detect
patient
long
symptom
onset
antibiot
therapi
howev
pcr
test
provid
high
throughput
capac
rapid
realtim
test
result
due
common
practic
batch
sampl
gain
effici
moreov
laboratori
diagnosi
respiratori
infect
affect
substanti
variat
collect
transport
method
emerg
us
food
drug
administr
fda
approv
autom
rapid
mega
multiplex
pcr
platform
rmpcr
biofir
salt
lake
citi
ut
exemplifi
technic
breakthrough
enabl
rapid
diagnosi
acut
viral
bacteri
respiratori
infect
swab
specimen
singl
molecular
panel
wellrecogn
pertussi
outbreak
washington
state
overlap
respiratori
viral
season
character
widespread
circul
influenza
respiratori
syncyti
viru
rsv
respiratori
virus
fig
rmpcr
filmarray
respiratori
virus
laboratorydevelop
pcr
ldpcr
three
pertussi
pathogen
b
pertussi
b
parapertussi
b
holmesii
deploy
outbreak
time
detect
b
pertussi
includ
within
panel
rmpcr
panel
result
unavail
laboratori
report
pend
fda
approv
b
pertussi
detect
result
obtain
post
hoc
follow
licensur
expand
rmpcr
panel
fda
octob
addit
increas
laboratori
util
high
throughput
ldpcr
pertussi
outbreak
diagnost
oper
also
includ
cultur
pcrposit
sampl
achiev
cultureposit
rate
use
statewid
epidemiolog
studi
pertussi
report
compar
result
inhous
enabl
batch
high
rapid
multiplex
rmpcr
assay
defin
perform
characterist
two
differ
approach
identifi
pertussi
pathogen
analyz
util
rmpcr
overlap
viral
respiratori
season
pediatr
urgent
care
hospitalbas
set
protocol
retrospect
cohort
studi
approv
seattl
children
institut
review
board
author
declar
compet
interest
could
potenti
influenc
data
analysi
conclus
analyz
specimen
collect
patient
age
birth
year
seattl
children
hospit
decemb
date
rmpcr
implement
replac
method
respiratori
viral
diagnosi
prior
pertussi
outbreak
juli
month
end
respiratori
viral
season
respiratori
viral
season
defin
post
hoc
period
time
encompass
peak
volum
submit
respiratori
specimen
specimen
patient
obtain
inpati
ambulatori
visit
includ
emerg
depart
ed
urgent
care
facil
elig
inclus
howev
time
period
fda
clear
rmpcr
restrict
test
report
respiratori
virus
ldpcr
specif
use
pertussi
diagnosi
post
hoc
data
recoveri
pertain
b
pertussi
detect
rmpcr
made
avail
manufactur
upon
fda
clearanc
expand
panel
octob
sampl
exclud
analysi
patient
underli
sever
immunosuppress
condit
hematolog
oncolog
malign
hematopoiet
stem
cell
transplant
intens
care
unit
unless
test
first
ed
due
frequent
repeat
test
activ
surveil
protocol
associ
patient
inclus
exclus
criteria
repeat
patient
specimen
follow
pertussi
ldpcr
diagnosi
repeat
specimen
patient
within
week
ident
result
posit
neg
exclud
respiratori
viral
diagnosi
rmpcr
repeat
specimen
result
detect
agent
period
exclud
detect
differ
virus
repeat
specimen
singl
patient
day
apart
consid
reflect
differ
infecti
episod
specimen
includ
independ
analysi
posit
neg
viral
result
report
specimen
obtain
within
day
period
posit
result
includ
differ
virus
detect
repeat
specimen
within
day
period
viral
agent
consid
singl
sampl
analysi
specimen
multipl
virus
detect
singl
swab
pediatrician
primari
care
physician
inform
local
health
jurisdict
statewid
pertussi
outbreak
period
regard
clinic
criteria
meet
case
definit
pertussi
whoop
cough
ill
publish
center
diseas
control
prevent
cdc
assess
physician
suspicion
pertussi
potenti
diagnosi
base
presenc
pertussi
laboratori
order
ldpcr
alon
respons
physician
assess
physician
suspicion
potenti
either
respiratori
viral
pertussi
infect
base
presenc
physician
order
pertussi
ldpcr
respiratori
virus
rmpcr
therefor
plan
evalu
three
group
cohort
analysi
children
suspect
pertussi
alon
ldpcr
pertussi
order
children
pertussi
suspect
rmpcr
respiratori
virus
order
children
suspect
viral
ill
andor
pertussi
ldpcr
rmpcr
order
deep
posterior
nasopharyng
np
specimen
collect
thinaluminum
wire
shaft
small
dacronrayon
swab
tip
hardi
diagnost
santa
maria
ca
kept
without
transport
medium
requir
daili
batch
test
ldpcr
nylon
flock
midturbin
midnt
swab
flexibl
plastic
shaft
rotat
inocul
univers
transport
medium
utm
copan
diagnost
brescia
itali
sent
promptli
rmpcr
two
length
nylon
flock
swab
use
circular
collar
ensur
standard
sampl
indic
depth
one
shaft
length
cm
code
children
year
cm
long
shaft
code
children
year
sampl
typic
collect
train
nurs
transport
laboratori
within
h
np
swab
refriger
h
delay
transport
anticip
np
specimen
elut
vortex
ml
salin
concentr
centrifug
ldpcr
design
detect
differenti
b
pertussi
b
parapertussi
b
holmesii
base
three
speciesdiscrimin
dna
target
melt
peak
characterist
addit
ldpcr
could
accommod
specimen
per
plate
h
batch
feed
thermocycl
specimen
surg
limit
detect
ldpcr
determin
show
reproduc
minimum
copi
per
pcr
reaction
consensu
criteria
interpret
result
use
target
either
posit
target
specif
melt
curv
ptx
promot
region
andor
reca
singl
reproduc
posit
target
accept
posit
conting
target
posit
test
rule
b
holmesii
carri
test
batch
result
typic
avail
within
h
bacteri
cultur
pertussi
perform
pcrposit
specimen
inocul
swab
post
pcr
elut
reganlow
agar
sheep
blood
agar
ad
specimen
posit
b
parapertussi
b
holmesii
phenotyp
coloni
reganlow
nonselect
blood
agar
speciat
confirm
ldpcr
midnt
swab
utm
submit
laboratori
room
temperatur
within
h
vortex
aliquot
solut
ad
rmpcr
card
accord
manufactur
specif
biofir
rmpcr
util
twostep
nest
multiplex
pcr
process
includ
primari
multiplex
pcr
follow
array
organismspecif
secondstag
pcr
reaction
rmpcr
pertussi
target
toxin
promot
region
cross
reactiv
b
parapertussi
observ
concentr
less
cfuml
although
limit
detect
list
filmarray
product
descript
b
pertussi
cfuml
verifi
sensit
test
approach
cfuml
use
serial
dilut
run
duplic
specif
rmpcr
panel
time
approv
detect
viral
pathogen
subtyp
includ
influenza
flu
influenza
b
flu
b
rsv
parainfluenza
virus
piv
human
metapneumoviru
hmpv
coronaviru
cov
adenoviru
adv
rhinovirusenteroviru
rhv
assay
detect
reveal
result
three
bacteri
pathogen
b
pertussi
c
pneumonia
pneumonia
fda
approv
octob
proport
compar
use
chi
squar
mcnemar
exact
chi
squar
twosampl
test
proport
oneway
anova
appropri
statist
analys
perform
use
stata
statacorp
colleg
station
tx
altogeth
np
specimen
test
ldpcr
met
inclus
criteria
analysi
midnt
specimen
test
rmpcr
includ
tabl
fig
patient
np
specimen
test
ldpcr
alon
design
cohort
n
tabl
fig
patient
midnt
specimen
test
rmpcr
alon
respiratori
viral
pathogen
design
cohort
n
tabl
fig
cohort
defin
group
patient
ldpcr
rmpcr
order
within
h
otherwis
describ
dualtest
specimen
n
tabl
fig
perform
ldpcr
rmpcr
detect
pertussi
pathogen
compar
dualtest
group
cohort
n
total
posit
specimen
detect
cohort
includ
b
pertussi
n
b
parapertussi
n
tabl
fig
combin
detect
pertussi
pathogen
total
n
includ
two
b
parapertussi
either
rmpcr
ldpcr
use
refer
standard
ldpcr
detect
rmpcr
detect
exclud
two
case
b
parapertussi
speci
includ
rmpcr
panel
ldpcr
detect
b
pertussi
rmpcr
detect
p
differ
proport
mcnemar
exact
chi
squar
two
case
b
pertussi
miss
ldpcr
posit
singl
target
reproduc
one
case
miss
rmpcr
posit
singl
target
reproduc
ldpcr
six
specimen
cohort
discord
result
one
specimen
posit
ldpcr
sampl
posit
rmpcr
tabl
median
age
subject
year
rang
week
year
respiratori
symptom
present
median
day
prior
test
rang
day
six
subject
cough
clinic
assess
four
report
cough
paroxysm
one
child
known
exposur
pertussi
occur
week
earlier
receiv
postexposur
prophylaxi
macrolid
antibiot
three
six
case
posit
rmpcr
pertussi
diagnos
anoth
facil
method
unknown
within
day
prior
evalu
institut
evalu
abil
clinician
recogn
pertussi
use
test
order
proxi
physician
recognit
pertussi
tabl
patient
cohort
n
includ
strongli
suspect
pertussi
ldpcr
request
cohort
patient
age
rang
day
year
median
year
interquartil
rang
iqr
year
rate
pertussi
detect
repres
case
b
pertussi
three
case
b
parapertussi
tabl
patient
cohort
n
specimen
submit
respiratori
viral
pathogen
detect
indic
pertussi
suspect
cohort
patient
age
rang
day
year
median
year
iqr
year
b
pertussi
detect
specimen
obtain
unblind
rmpcr
result
post
hoc
rate
significantli
differ
cohort
p
comparison
tabl
specimen
collect
cohort
n
individu
age
rang
year
median
year
iqr
year
whose
healthcar
provid
request
ldpcr
pertussi
rmpcr
respiratori
virus
patient
cohort
tend
younger
patient
two
cohort
proport
patient
month
age
cohort
cohort
cohort
p
chi
squar
detect
pertussi
pathogen
cohort
highest
three
cohort
b
parapertussi
tabl
four
children
cohort
respiratori
viral
test
order
pertussisspecif
test
pertussi
detect
rmpcr
base
data
recov
manufactur
post
hoc
includ
one
case
previous
diagnos
anoth
institut
median
age
subject
year
rang
week
year
median
durat
respiratori
symptom
prior
test
day
rang
day
four
subject
cough
clinic
find
cough
paroxysm
report
indic
receipt
macrolid
medic
record
pertussi
respiratori
viral
pathogen
present
respiratori
specimen
age
group
studi
month
tabl
fig
although
rate
viral
infect
cohort
known
overal
viral
detect
rate
cohort
high
respect
overal
p
tabl
respect
among
month
p
tabl
detect
rate
specif
virus
also
differ
cohort
particular
incid
influenza
flu
flu
b
higher
cohort
vs
p
contrast
cohort
higher
incid
rsv
vs
piv
vs
multipl
virus
vs
p
tabl
viral
coinfect
common
specimen
pertussi
three
four
specimen
posit
b
pertussi
cohort
also
virus
case
hmpv
one
flu
b
sixteen
specimen
posit
pertussi
pathogen
cohort
simultan
detect
viral
agent
rhv
cov
one
piv
hmpv
rsv
two
specimen
contain
one
viral
rhv
piv
cov
hmpv
bacteri
cultur
perform
specimen
posit
ldpcr
cohort
cohort
pertussi
pathogen
isol
specimen
n
b
pertussi
b
parapertussi
specimen
day
slow
turnaround
time
poor
diagnost
util
pertussi
cultur
tabl
rate
isol
viabl
organ
similar
p
cohort
cohort
none
specimen
discrep
find
ldpcr
rmpcr
posit
cultur
result
assess
abil
rmpcr
platform
ldpcr
test
detect
pertussi
pathogen
context
statewid
pertussi
epidem
base
retrospect
analysi
two
pcr
assay
achiev
similar
sensit
despit
differ
sampl
collect
media
amplif
technolog
also
found
clinician
rel
effect
identifi
children
higher
risk
pertussi
studi
demonstr
midnt
specimen
collect
nylon
flock
swab
np
specimen
collect
dacronrayon
swab
effect
b
pertussi
detect
result
similar
find
report
esposito
et
al
walsh
et
al
anecdot
center
use
midnt
swab
prefer
health
care
profession
depth
sampl
standard
age
appropri
visual
guid
approach
may
fact
promot
standard
collect
high
qualiti
specimen
past
decad
remark
progress
made
develop
rmpcr
method
concomit
rapid
diagnosi
viral
bacteri
respiratori
infect
result
suggest
similar
perform
rmpcr
ldpcr
method
identifi
pertussi
pathogen
although
unabl
cultur
pertussi
sampl
discord
result
case
like
true
posit
base
evid
exposur
pertussi
detect
pertussi
laboratori
andor
presenc
cough
paroxysm
possibl
discord
specimen
low
copi
number
b
pertussi
dna
andor
sampl
variat
case
miss
ldpcr
could
potenti
also
relat
pcr
inhibit
aluminumshaft
swab
limit
associ
design
rmpcr
includ
capac
test
one
specimen
time
detect
b
pertussi
consequ
emerg
b
parapertussi
b
holmesii
may
overlook
addit
use
antibioticcontain
media
specimen
collect
preclud
cultur
viabl
organ
necessit
molecular
epidemiolog
investig
accuraci
clinic
diagnosi
viral
versu
pertussi
infect
children
well
document
clinician
abil
identifi
patient
risk
pertussi
appear
rel
effect
studi
pertussi
pathogen
detect
time
frequent
dualtest
cohort
compar
order
viral
test
cohort
influenza
appear
recogn
clinician
well
nearli
twice
mani
laboratoryconfirm
flu
ab
case
occur
viralonli
test
cohort
compar
dual
test
cohort
vs
respect
p
retrospect
analysi
support
use
rmpcr
children
month
find
respiratori
virus
includ
multivir
coinfect
pertussi
significantli
higher
age
group
tabl
implement
innov
rmpcr
assay
includ
respiratori
viral
bacteri
pathogen
hospitalbas
laboratori
without
challeng
although
clinic
assess
effect
order
singl
test
produc
multipl
result
problemat
exist
laboratori
bill
model
govern
yet
caught
multiplex
pcr
platform
assign
commun
unrequest
agent
gener
broad
test
panel
potenti
caus
oper
challeng
reimburs
difficulti
laboratori
institut
studi
limit
retrospect
design
lack
complet
parallel
data
pertussi
respiratori
virus
everi
patient
visit
also
note
studi
occur
period
high
awar
pertussi
diseas
howev
unsolicit
test
select
specimen
collect
multipl
clinician
combin
abil
obtain
pertussi
data
viral
test
specimen
retrospect
permit
analysi
physician
clinic
decis
make
without
studi
bia
experi
pertussi
epidem
demonstr
diagnost
acumen
clinician
abil
use
midnas
flock
swab
detect
pertussi
without
compromis
sensit
compar
np
specimen
correl
result
integr
bacterialvir
rmpcr
assay
laborintens
wellestablish
multitarget
ldpcr
assay
specimen
surg
rmpcr
platform
abil
identifi
relev
respiratori
pathogen
quickli
implic
optim
treatment
infect
prevent
manag
younger
children
